Cargando…

Targeting dendritic cells in pancreatic ductal adenocarcinoma

Dendritic cells (DC) are an integral part of the tumor microenvironment. Pancreatic cancer is characterized by reduced number and function of DCs, which impacts antigen presentation and contributes to immune tolerance. Recent data suggest that exosomes can mediate communication between pancreatic ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deicher, Anton, Andersson, Roland, Tingstedt, Bobby, Lindell, Gert, Bauden, Monika, Ansari, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006559/ https://www.ncbi.nlm.nih.gov/pubmed/29946224 http://dx.doi.org/10.1186/s12935-018-0585-0

Ejemplares similares

Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
por: Bauden, Monika, et al.
Publicado: (2017)

Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018)

Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018)

Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment
por: Ansari, Daniel, et al.
Publicado: (2018)

Immune checkpoint therapy for pancreatic cancer
por: Johansson, Henrik, et al.
Publicado: (2016)

The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data
por: Bengtsson, Axel, et al.
Publicado: (2020)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2019)

Early onset pancreatic cancer: a controlled trial
por: Tingstedt, Bobby, et al.
Publicado: (2011)

Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
por: Bauden, Monika, et al.
Publicado: (2015)

Potential biomarkers for early detection of pancreatic ductal adenocarcinoma
por: Kriz, D., et al.
Publicado: (2020)

Targeting histone deacetylases in pancreatic ductal adenocarcinoma
por: Schneider, Günter, et al.
Publicado: (2010)

Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment
por: Cruz-Monserrate, Zobeida, et al.
Publicado: (2014)

Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
por: Byrling, J., et al.
Publicado: (2021)

Prevention of Pleural Adhesions by Bioactive Polypeptides - A Pilot Study
por: Åkerberg, D., et al.
Publicado: (2013)

Surgical exploration without resection in pancreatic and periampullary tumors: Report from a national database
por: Sahlström, Emil, et al.
Publicado: (2020)

Apoptotic pathways in pancreatic ductal adenocarcinoma
por: Hamacher, Rainer, et al.
Publicado: (2008)

Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma
por: Plesca, Ioana, et al.
Publicado: (2022)

Targeting mTOR in Pancreatic Ductal Adenocarcinoma
por: Iriana, Sentia, et al.
Publicado: (2016)

Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
por: Sato, Norihiro, et al.
Publicado: (2016)

Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
por: Raufi, Alexander G., et al.
Publicado: (2021)

Galanin 2 Receptor: A Novel Target for a Subset of Pancreatic Ductal Adenocarcinoma
por: Namsolleck, Pawel, et al.
Publicado: (2023)

The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
por: Wu, Yang, et al.
Publicado: (2021)

Enrichment of Murine CD68(+)CCR2(+) and CD68(+)CD206(+) Lung Macrophages in Acute Pancreatitis-Associated Acute Lung Injury
por: Akbarshahi, Hamid, et al.
Publicado: (2012)

Mast cells in pancreatic ductal adenocarcinoma
por: Chang, David Z.
Publicado: (2012)

Advanced Pancreatic Ductal Adenocarcinoma: Moving Forward
por: Franck, Caspar, et al.
Publicado: (2020)

Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma
por: Kelly, Kimberly A, et al.
Publicado: (2008)

Super-enhancers: novel target for pancreatic ductal adenocarcinoma
por: Ghosh, Chandrayee, et al.
Publicado: (2019)

Splice variants as novel targets in pancreatic ductal adenocarcinoma
por: Wang, Jun, et al.
Publicado: (2017)

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2020)

Key drug-targeting genes in pancreatic ductal adenocarcinoma
por: Sakharkar, Meena Kishore, et al.
Publicado: (2021)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

Comparative Characterization of Stroma Cells and Ductal Epithelium in Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma
por: Helm, Ole, et al.
Publicado: (2014)

Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma
por: Bubin, Roman, et al.
Publicado: (2023)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
por: Pezzilli, Raffaele, et al.
Publicado: (2011)

Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma
por: Rai, Vikrant, et al.
Publicado: (2020)

Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Skorupan, Nebojsa, et al.
Publicado: (2022)

Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
por: Kung, Heng‐Chung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0gmpli0t3pcircpknot57qs8m5